Herpes viruses and human papillomavirus in prostate cancer: first results

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are among the most common urological diseases in men. It has been repeatedly suggested that viral infection plays an important role in prostate carcinogenesis.

Aim. To assess the relationship between viral infection and PCa, as well as the clinical and morphological features of BPH and PCa.

Materials and methods. A total of 98 patients undergoing treatment for BPH (n=48) or PCa (n=50) between 2019 and 2021 were included in the study. Real-time PCR on the surgical specimens for human papillomaviruses (HPV), herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes virus type 6 (HSV-6) was performed.

Results. In patients with PCa, viruses in prostate tissue were found more often compared to those with BPH (50.0 vs. 31.3%, respectively, p=0.046.) The most common virus in both PCa and BPH was EBV (22.0 vs. 16.7%, respectively). The second most common virus in patients with PCa was HSV-6 (20.0%), which was not detected in any men with BPH (p=0.003). There was a trend toward higher prevalence of CMV among patients with PCa (16.0% vs. 4.2%), but the difference was not significant (p=0.09). There was no association of viral infection with clinical and morphological features.

Conclusions. The resulting trend toward a higher prevalence of HSV-6 and CMV in patients with PCa compared to those with BPH creates the prerequisites for further study of viruses in prostate diseases involving a larger cohort, which will provide an idea of the multi-stage process of malignant transformation and, possibly, open new therapeutic options for prevention and treatment.

Full Text

Restricted Access

About the authors

L. M. Mikhaleva

Russian Scientific Center of Surgery named after Academician B.V. Petrovsky; “GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Author for correspondence.
Email: mikhalevalm@yandex.ru

corresponding member of RAS, Ph.D., MD, professor, Director of Scientific and research Institute of Human Morphology named after Academician A.P. Avtsyn, Head of Department of Pathology

Russian Federation, Moscow; Moscow

А. А. Kamalov

Medical Scientific and Educational Center of Lomonosov Moscow State University; Moscow State University by Lomonosov; “GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Email: armais.kamalov@rambler.ru

Academician of the RAS, Ph.D., MD, professor, Director, Head of the Department of Urology and Andrology, Faculty of Fundamental Medicine

Russian Federation, Moscow; Moscow; Moscow

V. K. Karpov

Medical Scientific and Educational Center of Lomonosov Moscow State University; Moscow State University by Lomonosov; “GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Email: vk_karpov@mail.ru

Ph.D., associate professor at the Department of Urology and Andrology, Faculty of Fundamental Medicine

Russian Federation, Moscow; Moscow; Moscow

D. A. Okhobotov

Medical Scientific and Educational Center of Lomonosov Moscow State University; Moscow State University by Lomonosov

Email: 14072003m@gmail.com

Ph.D., MD, associate professor, Department of Urology and Andrology, Faculty of Fundamental Medicine

Russian Federation, Moscow; Moscow

E. P. Akopyan

Russian Scientific Center of Surgery named after Academician B.V. Petrovsky; “GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Email: vanilsheep@yandex.ru

pathologist

Russian Federation, Moscow; Moscow

N. K. Shakhpazyan

Russian Scientific Center of Surgery named after Academician B.V. Petrovsky; “GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Email: nshakhpazyan@gmail.com

pathologist

Moscow; Moscow

B. M. Shaparov

Moscow State University by Lomonosov

Email: uroboris@mail.ru

urologist

Russian Federation, Moscow

O. Yu. Nesterova

Medical Scientific and Educational Center of Lomonosov Moscow State University; Moscow State University by Lomonosov

Email: oy.nesterova@gmail.com

Ph.D., senior tutor at the Department of Urology and Andrology, Faculty of Fundamental Medicine

Russian Federation, Moscow; Moscow

L. K. Martirosyan

Medical Scientific and Educational Center of Lomonosov Moscow State University; Moscow State University by Lomonosov

Email: mlyovchik@mail.ru

resident at the Department of Urology and Andrology, Faculty of Fundamental Medicine

Russian Federation, Moscow; Moscow

М. М. Ekhoyan

“GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Email: miso83@list.ru

urologist

Russian Federation, Moscow

О. А. Osmanov

Medical Scientific and Educational Center of Lomonosov Moscow State University; Moscow State University by Lomonosov; “GKB №31” named after academician G.M. Savelieva of Moscow Healthcare Department

Email: omar_osmanov07@mail.ru

urologist, student at the Department of Urology and Andrology, Faculty of Fundamental Medicine

Russian Federation, Moscow; Moscow; Moscow

References

  1. Cancer Taday. https://gco.iarc.fr/today/home
  2. Rao D., Yu H., Bai Y., et al. Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis. OncoTargets and therapy. New Zealand. 2015; 8:2817–2826.
  3. Sutcliffe S. Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future oncology (London, England). England. 2010;6(8):1289–1311.
  4. Kamalov A.A., Mikhaleva L.M., Matveev V.B., et al. Viral infections in prostate carcinogenesis: a literature review. Oncourology. 2022;18(2):182–189. Russian (Камалов А.А., Михалева Л.М., Матвеев В.Б., et al. Вирусные инфекции в канцерогенезе предстательной железы: обзор литературы. Онкоурология. 2022;18(2):182–189).
  5. Hrbacek J., Urban M., Hamsikova E., et al. Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review. Urologic oncology. United States. 2013;31(7):951–965.
  6. Pimple S., Mishra G. Cancer cervix: Epidemiology and disease burden. CytoJournal. United States. 2022;19:21.
  7. Salnikov M., Prusinkiewicz M.A., Lin S., et al. Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion. Viruses. Switzerland. 2023;15(1).
  8. Escudero A.L., Luque R.J., Quintero A., et al. Association of human herpesvirus type 6 DNA with human bladder cancer. Cancer letters. Ireland. 2005;230(1):20–24.
  9. Mikhaleva L.M., Pechnikova V. V, Pshikhachev A.M., et al. Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns. Current medicinal chemistry. United Arab Emirates. 2021;28(41):8517–8533.
  10. Yin Y., Liu H., Luo M., et al. Primary extranodal soft tissue Lennert lymphoma (lymphoepithelioid variant of peripheral T-cell lymphoma, unspecified): a case report and review of the literature. Diagnostic pathology. England. 2023;18(1):12.
  11. Ge X., Wang X., Shen P. Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: A meta-analysis. Biomedical reports. England. 2013;1(3):433–439.
  12. Yang L., Xie S., Feng X., et al. Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis. Scientific reports. England. 2015;5:14667.
  13. Volgareva G.M., Ermilova V.D. Detection of oncogene E7 of human papillomavirus type 18 in patients with prostate cancer. Russian Biotherapeutic Journal. 2019;18(1):37–4. Russian (Волгарева Г.М., Ермилова В.Д. Обнаружение онкогена Е7 вируса папилломы человека 18-го типа у больных раком предстательной железы. Российский биотерапевтический журнал. 2019;18(1):37–41).
  14. Russo G.I., Calogero A.E., Condorelli R.A., et al. Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis. The aging male : the official journal of the International Society for the Study of the Aging Male. England. 2020;23(2):132–138.
  15. Lin Y., Mao Q., Zheng X., et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis. Irish journal of medical science. Ireland. 2011;180(2):497–503.
  16. Plummer M., de Martel C., Vignat J., et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet. Global health. England. 2016;4(9):e609-616.
  17. Catalfamo C.J., Brown H.E., Dennis L.K. Evaluating the Strength of Association of Human Papillomavirus Infection With Penile Carcinoma: A Meta-Analysis. Sexually transmitted diseases. United States. 2022;49(5):368–376.
  18. Sun J.-X., Xu J.-Z., Liu C.-Q., et al. The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample mendelian randomization. Journal of medical virology. United States. 2023;95(1):P. e28208.
  19. Lawson J.S., Glenn W.K. Multiple pathogens and prostate cancer. Infectious agents and cancer. England. 2022;17(1):23.
  20. Doniger J., Muralidhar S., Rosenthal L.J. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clinical microbiology reviews. United States. 1999;12(3):367–382.
  21. Soroceanu L., Cobbs C.S. Is HCMV a tumor promoter? Virus research. Netherlands, 2011;157(2):193–203.
  22. Samsonov R.B., Klochkova T.G., Yevtushenko V.I. Infection of the prostate gland with viruses of the herpesviridae and hpv family in patients with prostate cancer. Issues of oncology. 2012;58(6):795–799. Russian (Самсонов Р.Б., Клочкова Т.Г., Евтушенко В.И. Инфицированность предстательной железы вирусами семейства herpesviridae и hpv у больных раком простаты. Вопросы онкологии. 2012;58(6):795–799).
  23. Samsonov R.B., Klochkova T.G., Yevtushenko V.I. Changes in infection of prostate tissue with viruses of the herpesviridae and hpv family in patients with prostate cancer depending on the stage of the pathological process. Issues of oncology. 2016;62(4):504–507. Russian (Самсонов Р.Б., Клочкова Т.Г., Евтушенко В.И. Изменения инфицированности ткани предстательной железы вирусами семейства herpesviridae и hpv у больных раком простаты в зависимости от стадии патологического процесса. Вопросы онкологии. 2016;62(4):504–507).
  24. Sutcliffe S., Platz E.A. Inflammation and prostate cancer: a focus on infections. Current urology reports. United States. 2008;9(3):243–249.
  25. Lezhnyova V., Davidyuk Y., Mullakhmetova A., et al. Analysis of herpesvirus infection and genome single nucleotide polymorphism risk factors in multiple sclerosis, Volga federal district, Russia. Frontiers in immunology. Switzerland. 2022;13:P. 1010605.
  26. Siddon A., Lozovatsky L., Mohamed A., et al. Human herpesvirus 6 positive Reed-Sternberg cells in nodular sclerosis Hodgkin lymphoma. British journal of haematology. England. 2012;158(5):635–643.
  27. Salahuddin S.Z., Snyder K.A., Godwin A., et al. The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell. Virology journal. England. 2007;4:106.
  28. Gabrielli L., Balboni A., Borgatti E.C., et al. Inherited Chromosomally Integrated Human Herpesvirus 6: Laboratory and Clinical Features. Microorganisms. Switzerland. 2023;11:3.
  29. Sarshari B., Mohebbi S.R., Ravanshad M., et al. Detection and quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6 in stomach frozen tissue of chronic gastritis and gastric cancer patients. Microbiology and immunology. Australia. 2022;66(8):379–385.
  30. Sultanova A., Chistjakovs M., Chapenko S., et al. Possible interference of human beta-herpesviruses-6 and -7 in gastrointestinal cancer development. Experimental oncology. Ukraine. 2013;35(2):93–96.
  31. Gulve N., Rudel T. Chlamydia trachomatis and human herpesvirus 6 infections in ovarian cancer-Casual or causal? PLoS pathogens. United States. 2019;15(11):e1008055.
  32. Gravel A., Dubuc I., Brooks-Wilson A., et al. Inherited Chromosomally Integrated Human Herpesvirus 6 and Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. United States. 2017;26(3):425–427.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Figure.

Download (160KB)
Indexing metadata

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies